77 related articles for article (PubMed ID: 18701276)
1. Highly functionalized 7-azaindoles as selective PPAR gamma modulators.
Debenham SD; Chan A; Lau FW; Liu W; Wood HB; Lemme K; Colwell L; Habulihaz B; Akiyama TE; Einstein M; Doebber TW; Sharma N; Wang CF; Wu M; Berger JP; Meinke PT
Bioorg Med Chem Lett; 2008 Sep; 18(17):4798-801. PubMed ID: 18701276
[TBL] [Abstract][Full Text] [Related]
2. Selective PPARgamma modulators with improved pharmacological profiles.
Liu K; Black RM; Acton JJ; Mosley R; Debenham S; Abola R; Yang M; Tschirret-Guth R; Colwell L; Liu C; Wu M; Wang CF; MacNaul KL; McCann ME; Moller DE; Berger JP; Meinke PT; Jones AB; Wood HB
Bioorg Med Chem Lett; 2005 May; 15(10):2437-40. PubMed ID: 15863293
[TBL] [Abstract][Full Text] [Related]
3. Benzoyl 2-methyl indoles as selective PPARgamma modulators.
Acton JJ; Black RM; Jones AB; Moller DE; Colwell L; Doebber TW; Macnaul KL; Berger J; Wood HB
Bioorg Med Chem Lett; 2005 Jan; 15(2):357-62. PubMed ID: 15603954
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists.
Dropinski JF; Akiyama T; Einstein M; Habulihaz B; Doebber T; Berger JP; Meinke PT; Shi GQ
Bioorg Med Chem Lett; 2005 Nov; 15(22):5035-8. PubMed ID: 16153845
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists.
Shi Q; Canada EJ; Xu Y; Warshawsky AM; Etgen GJ; Broderick CL; Clutinger CK; Irwin LA; Laurila ME; Montrose-Rafizadeh C; Oldham BA; Wang M; Winneroski LL; Xie C; York JS; Yumibe NP; Zink RW; Mantlo N
Bioorg Med Chem Lett; 2007 Dec; 17(24):6744-9. PubMed ID: 18029178
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia.
Liu W; Liu K; Wood HB; McCann ME; Doebber TW; Chang CH; Akiyama TE; Einstein M; Berger JP; Meinke PT
J Med Chem; 2009 Jul; 52(14):4443-53. PubMed ID: 19530681
[TBL] [Abstract][Full Text] [Related]
7. Azaindoles as potent CRTH2 receptor antagonists.
Simard D; Leblanc Y; Berthelette C; Zaghdane MH; Molinaro C; Wang Z; Gallant M; Lau S; Thao T; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Houle R; Lévesque JF
Bioorg Med Chem Lett; 2011 Jan; 21(2):841-5. PubMed ID: 21185722
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists.
Kuhn B; Hilpert H; Benz J; Binggeli A; Grether U; Humm R; Märki HP; Meyer M; Mohr P
Bioorg Med Chem Lett; 2006 Aug; 16(15):4016-20. PubMed ID: 16737814
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.
Hopkins CR; O'neil SV; Laufersweiler MC; Wang Y; Pokross M; Mekel M; Evdokimov A; Walter R; Kontoyianni M; Petrey ME; Sabatakos G; Roesgen JT; Richardson E; Demuth TP
Bioorg Med Chem Lett; 2006 Nov; 16(21):5659-63. PubMed ID: 16919947
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of novel indole derivatives as potent and selective PPARgamma modulators.
Lamotte Y; Martres P; Faucher N; Laroze A; Grillot D; Ancellin N; Saintillan Y; Beneton V; Gampe RT
Bioorg Med Chem Lett; 2010 Feb; 20(4):1399-404. PubMed ID: 20079636
[TBL] [Abstract][Full Text] [Related]
11. Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma.
Connors RV; Wang Z; Harrison M; Zhang A; Wanska M; Hiscock S; Fox B; Dore M; Labelle M; Sudom A; Johnstone S; Liu J; Walker NP; Chai A; Siegler K; Li Y; Coward P
Bioorg Med Chem Lett; 2009 Jul; 19(13):3550-4. PubMed ID: 19464171
[TBL] [Abstract][Full Text] [Related]
12. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
[TBL] [Abstract][Full Text] [Related]
13. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
14. Selective, potent PPARgamma agonists with cyclopentenone core structure.
Otero MP; Pérez Santín E; Rodríguez-Barrios F; Vaz B; de Lera AR
Bioorg Med Chem Lett; 2009 Apr; 19(7):1883-6. PubMed ID: 19275963
[TBL] [Abstract][Full Text] [Related]
15. PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation.
Ren Y; Sun C; Sun Y; Tan H; Wu Y; Cui B; Wu Z
Vascul Pharmacol; 2009; 51(2-3):169-74. PubMed ID: 19540934
[TBL] [Abstract][Full Text] [Related]
16. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists.
Zhang H; Ryono DE; Devasthale P; Wang W; O'Malley K; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Locke K; Zhang L; Lippy J; Kunselman L; Morgan N; Flynn N; Moore L; Hosagrahara V; Zhang L; Kadiyala P; Xu C; Doweyko AM; Bell A; Chang C; Muckelbauer J; Zahler R; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2009 Mar; 19(5):1451-6. PubMed ID: 19201606
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists.
Kim E; Park CS; Han T; Bae MH; Chong W; Lee CH; Shin YA; Ahn BN; Kim MK; Shin CY; Son MH; Kim JK; Moon HS; Shim HJ; Kim EJ; Kim SH; Lim JI; Lee CH
Bioorg Med Chem Lett; 2008 Sep; 18(18):4993-6. PubMed ID: 18771917
[TBL] [Abstract][Full Text] [Related]
19. 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations.
Parmenon C; Guillard J; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Dacquet C; Ktorza A; Viaud-Massuard MC
Bioorg Med Chem Lett; 2009 May; 19(10):2683-7. PubMed ID: 19376700
[TBL] [Abstract][Full Text] [Related]
20. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
